Article info

Download PDFPDF
Low-Dose, Prophylactic, Extended-Field, Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin for Patients With Stage IB2-IIIB Cervical Cancer, Positive Pelvic Lymph Nodes, and Negative Para-aortic Lymph Nodes

Authors

  • Ji-An Liang Department of Radiation Therapy and Oncology, China Medical University Hospital, andCollege of Medicine, China Medical University, Taichung; PubMed articlesGoogle scholar articles
  • Shang-Wen Chen Department of Radiation Therapy and Oncology, China Medical University Hospital, andCollege of Medicine, China Medical University, Taichung;College of Medicine, Taipei Medical University, Taipei; and PubMed articlesGoogle scholar articles
  • Yao-Ching Hung College of Medicine, Taipei Medical University, Taipei; andDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan. PubMed articlesGoogle scholar articles
  • Lian-Shung Yeh College of Medicine, Taipei Medical University, Taipei; andDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan. PubMed articlesGoogle scholar articles
  • Wei-Chun Chang College of Medicine, Taipei Medical University, Taipei; andDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan. PubMed articlesGoogle scholar articles
  • Wu-Chou Lin College of Medicine, Taipei Medical University, Taipei; andDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan. PubMed articlesGoogle scholar articles
  • Yin-Yi Chang College of Medicine, Taipei Medical University, Taipei; andDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Shang-Wen Chen, MD, Department of Radiation Oncology, China Medical University Hospital, No. 2, Yuh-Der Rd, Taichung, Taiwan 404. E-mail: vincent1680616{at}yahoo.com.tw.

Citation

Liang J, Chen S, Hung Y, et al
Low-Dose, Prophylactic, Extended-Field, Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin for Patients With Stage IB2-IIIB Cervical Cancer, Positive Pelvic Lymph Nodes, and Negative Para-aortic Lymph Nodes

Publication history

  • Received January 19, 2013
  • Accepted June 6, 2013
  • First published June 1, 2014.
Online issue publication 
June 01, 2014

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.